Lower airway inflammation in infants with cystic fibrosis detected by newborn screening

Pediatric Pulmonology

Volumn 40, Issue 6, 2005, Pages 500-510

  Armstrong, David S ^a   Hook, Sarah M ^b   Jamsen, Kris M ^c   Nixon, Gillian M ^d   Carzino, Rosemary ^d   Carlin, John B ^c   Robertson, Colin F ^d   Grimwood, Keith ^e  

^a MONASH UNIVERSITY   (Australia)

^b MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bronchoalveolar lavage; Child; Cystic fibrosis; Cytokines; IL 1 ; IL 10; IL 6; IL 8; Infection; Inflammation; TNF

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; ELASTASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; INFLAMMATION; LONGITUDINAL STUDY; LOWER RESPIRATORY TRACT INFECTION; LUNG DISEASE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN DISEASE; NEWBORN SCREENING; PRIORITY JOURNAL;

BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; CYTOKINES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; LEUKOCYTE ELASTASE; LONGITUDINAL STUDIES; MALE; NEONATAL SCREENING; NEUTROPHILS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS;

EID: 28344451370     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20294     Document Type: Article

References (49)

1. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997;24:137-142.
2. Dean TP, Dai Y, Shute JK, Church MK, Warner JO. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res 1993;34:159-161.
3. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-2118.
4. 4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003;167:1109-1112.
5. Bonfield TL, Konstan MW, Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999;104:72-78.
6. Esterley JR, Oppenheimer EH. Cystic fibrosis of the pancreas: structural changes in peripheral airways. Thorax 1968;23:670-675.
7. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Br Med J [Clin Res] 1995;310:1571-1572.
8. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-1082.
9. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156:1197-1204.
10. Wilmott RW, Kassab JT, Kilian PL, Benjamin WR, Douglas SD, Wood RE. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 1990;142:365-368.
11. Hull J, Vervaart P, Grimwood K, Phelan P. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 1997;52:557-560.
12. Noah TL, Black HR, Cheng P-W, Wood RE, Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 1997;175:638-647.
13. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999;160:186-191.
14. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001;32:356-366.
15. Muhlebach MS, Noah TL. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am J Respir Crit Care Med 2002;165:911-915.
16. Dakin CL, Numa AH, Wang H, Morton JR, Vertzyas CC, Henry RL. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002;165:904-910.
17. Muhlebach MS, Reed W, Noah TL. Quantitative cytokine gene expression in CF airway. Pediatr Pulmonol 2004;37:393-399.
18. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994;150:448-454.
19. Cunningham S, McCol JR, Mallinson A, Boyd I, Marshall TG. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis. Pediatr Pulmonol 2003;36:43-48.
20. Cantin A. Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med 1995;151:939-941.
21. Chmiel JF, Berger M, Konstan MW. The role of inflammation in the pathophysiology of CF lung disease. Clin Rev Allergy Immunol 2002;23:5-27.
22. Tirouvanziam R, Khazaal I, Peault B. Primary inflammation in human cystic fibrosis small airways. Am J Physiol Lung Cell Mol Physiol 2002;283:445-451.
23. Kammouni W, Figarella C, Marchand S, Merten M. Altered cytokine production by cystic fibrosis tracheal gland serous cells. Infect Immun 1997;65:5176-5183.
24. Stecenko AA, King G, Torii K, Breyer RM, Dworski R, Blackwell TS, Christman JW, Brigham JL. Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 2001;25:145-155.
25. Scheid P, Kempster L, Griesenbach U, Davies JC, Dewar A, Weber PP, Colledge WH, Evans MJ, Geddes DM, Alton EWFW. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J 2001;17:27-35.
26. Aldallal N, McNaughton EE, Manzel LJ, Richards AM, Zabner J, Ferkol TW, Look DC. Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am J Respir Crit Care Med 2002;166:1248-1256.
27. Becker MN, Sauer SS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW, Randell SH. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 2004;169:645-653.
28. Massie RJ, Olsen M, Glazner J, Robertson CF, Francis I. Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). Med J Aust 2000;172:584-587.
29. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996;21:267-275.
30. Stata Corp. 2004. Stata statistical software: release 8.0. College Station, TX: Stata Corp.
31. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Hull J, Olinsky A, Phelan PD. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 1998;26:371-379.
32. Gutierrez JP, Grimwood K, Armstrong DS, Carlin JB, Carzino R, Olinsky A, Robertson CF, Phelan PD. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur Respir J 2001;17:281-286.
33. Nixon G, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K, Wainwright C. Early airway infection, inflammation, and lung function in cystic fibrosis. Arch Dis Child 2002;87:306-311.
34. Birrer P, McElvaney NG, Rudeberg A, Wirz Sommer C, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal RG. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994;150:207-213.
35. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995;20:63-70.
36. Gilljam M, Moltyaner Y, Downey GP, Devlin R, Durie P, Cantin AM, Tullis DE. Airway inflammation and infection in congenital bilateral absence of the vas deferens. Am J Respir Crit Care Med 2004;169:174-179.
37. Grigg J, Riedler J, Robertson CF. Bronchoalveolar lavage fluid cellularity and soluble intercellular adhesion molecule-1 in children with colds. Pediatr Pulmonol 1999;28:109-116.
38. Ratjen F, Rietschel E, Griese M, Ballmann M, Kleinau I, Doring G, Reinhardt D, Paul K. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function: Bronchoalveolar Lavage for the Evaluation of Anti-inflammatory Treatment (BEAT) Study Group. Eur Respir J 2000; 15:141-145.
39. Ratjen F, Bredendiek M, Brendel M, Meltzer J, Costabel U. Differential cytology of bronchoalveolar lavage fluid in normal children. Eur Respir J 1994;7:1865-1870.
40. Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Doring G, van Koningsbruggen S, Wahn U, Ratjen F, for the Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med 2004;169:719-725.
41. Kelly MM, Leigh R, Carruthers S, Horsewood P, Gleich GJ, Hargreave FE, Cox G. Increased detection of interleukin-5 in sputum by addition of protease inhibitors. Eur Respir J 2001;18:685-691.
42. Grimwood K, Hook S, Carzino R, Nixon G, Armstrong D. Cytokine expression within the lower airways of infants and young children with cystic fibrosis. Pediatr Pulmonol [Suppl] 1999;19:501.
43. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Hoiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. Acta Pathol Microbiol Immunol Scand 2000;108:329-335.
44. Koller DY, Nething I, Otto J, Urbanek R, Eichler I. Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity. Am J Respir Crit Care Med 1997;155:1050-1054.
45. Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin PL, Ramsey B, Cystic Fibrosis Therapeutics Development Network Study Group. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003;167:841-849.
46. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704.
47. Wilmott RW. Cytokines in cystic fibrosis. In: Nelson S, Martin TR, editors. Cytokines in pulmonary disease. New York: Marcel Dekker, Inc.; 2000. p 307-330.
48. Midulla F, Guidi R, Tancredi G, Quattrucci S, Ratjen F, Bottero S, Vestiti K, Francalanci P, Cutrera R. Microaspiration in infants with laryngomalacia. Laryngoscope 2004;114:1592-1596.
49. Midulla F, Villani A, Merollo R, Bjermer L, Sandstrom T, Ronchetti R. Bronchoalveolar lavage studies in children without parenchymal lung disease: cellular constituents and protein levels. Pediatr Pulmonol 1995;20:112-118.